Results for tag: "Periodic Fever Syndrome Drug"

The Periodic Fever Syndrome Drug market is a subset of the Immune Disorders Drugs market. It is composed of drugs used to treat periodic fever syndromes, a group of rare autoinflammatory diseases. These drugs are used to reduce inflammation and fever, and to prevent recurrent episodes of the disease. They are typically prescribed in combination with other treatments, such as lifestyle modifications and non-steroidal anti-inflammatory drugs. Commonly prescribed drugs include biologics, such as interleukin-1 inhibitors, and small molecule drugs, such as colchicine. The Periodic Fever Syndrome Drug market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more